ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: As shown in Figure 7B and Figures S8 and S16A, in the Supporting Information, PMIBcr/Abl‐R6 showed highly efficient apoptosis induction in both Bcr/Abl‐positive CML and ALL.